Effect of seed crystals of uric acid and monosodium urate on the crystallization of calcium oxalate in undiluted human urine in vitro

Clinical Science

Volumn 92, Issue 2, 1997, Pages 205-213

  Grover, Phulwinder K ^a   Ryall, Rosemary L ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Calcium oxalate crystallization; Epitaxy; Hyperuricosuria; Monosodium urate seeds; Uric acid seeds; Urine; Urolithiasis

Indexed keywords

CALCIUM OXALATE; CARBON 14; URATE; URIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; HUMAN; HYPERURICOSURIA; ISOTOPE LABELING; MALE; NORMAL HUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STONE FORMATION;

EID: 0031016701     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0920205     Document Type: Article

References (38)

1. Ryall RL, Grover PK, Marshall VR. Urate and calcium stones: picking up a drop of mercury with one's fingers? Am J Kidney Dis 1991; 17: 426-30.
2. Grover PK, Ryall RL. Urate and calcium oxalate stones: from repute to rhetoric to reality. Miner Electrolyte Metab 1994; 20: 361-70.
3. Coe FL, Raisen OL. Allopurinol treatment of uric-acid disorders in calcium-stone formers. Lancet 1973; 1: 129-31.
4. Coe FL, Kavalach AG. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med 1974; 291: 1344-50.
5. Smith MJV, Boyce WH. Allopurinol and urolithiasis. J Urol 1969; 102: 750-3.
6. Pak CYC, Barilla DE, Holt K, Brinkey L, Tolentino R, Zerwekh JE. Effect of oral purine load and allopurinol on the crystallization of calcium salts in urine of patients with hyperuricosuric calcium urolithiasis. Am J Med 1978; 65: 593-9.
7. Miano L, Petta S, Gallucci M. Allopurinol in the prevention of calcium oxalate renal stones. Eur Urol 1979; 5: 229-32.
8. Maschio G, Tessitore N, D'Angelo A, et al. Prevention of calcium nephrolithiasis with low dose thiazide, amiloride and allopurinol. Am J Med 1981; 71: 623-6.
9. Smith MJV. Placebo versus allopurinol for recurrent urinary calculi. Proc EDTA 1983; 20: 422-6.
10. Ettinger B, Tang A, Citron JT, Livermore B, Williams T. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 1986; 315: 1386-9.
11. Royer L. Experimental research on parallel growth on mutual orientation of crystals of different species. Bull Soc Fr Mineral 1928; 51: 7-159.
12. Modlin M. The aetiology of renal stones: A new concept arising from studies in a stone-free population. Ann R Coll Surg Engl (London) 1967; 40: 155-78.
13. Lonsdale K. Epitaxy as a growth factor in urinary calculi and gallstones. Nature (London) 1968; 217: 56-8.
14. Coe FL, Lawton RN, Goldstein RB, Tembe V. Sodium urate accelerates precipitation of calcium oxalate in vitro. Proc Soc Exp Biol Med 1975; 149: 926-9.
15. Pak CYC, Arnold LH. Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate. Proc Soc Exp Biol Med 1975; 149: 930-2.
16. Meyer JL, Bergert JH, Smith LH. The epitaxially induced crystal growth of calcium oxalate by crystalline uric acid. Invest Urol 1976; 14: 115-19.
17. Koutsoukos PG, Lam-Erwin CY, Nancollas GH. Epitaxial considerations in urinary stone formation. I. The urate-oxalate-phosphate system. Invest Urol 1980; 18: 178-84.
18. Mandel NS, Mandel GS. Epitaxis between stone-forming crystals at atomic level. In: Smith LH, Robertson WG, Finlayson B, eds. Urolithiasis: clinical and basic research. New York: Plenum Press, 1981: 469-80.
19. Deganello S, Coe F. Epitaxy between uric acid and whewellite: experimental verification. N Jb Miner Mh 1983; 6: 270-6.
20. Deganello S, Chou C. The uric add-whewellite association in human kidney stones. Scan Electron Microsc 1984; II: 927-33.
21. Sarig S, Hirsch D, Garti N, Goldwasser B. An extension of the concept of epitaxial growth. J Crystal Growth 1984; 69: 91-5.
22. Tiselius HG. Effects of sodium urate and uric acid crystals on the crystallization of calcium oxalate. Urol Res 1984; 12: 11-15.
23. Grases F, Conte A, Gil JJ. Simple method for the study of heterogenous nucleation in calcium oxalate urolithiasis. Br J Urol 1988; 61: 468-73.
24. Grover PK, Ryall RL, Marshall VR. Effect of urate on calcium oxalate crystallization in human urine: evidence for a promotory role of hyperuricosuria in urolithiasis. Clin Sci 1990; 79: 9-15.
25. Doyle IR, Ryall RL, Marshall VR. The effect of low-speed centrifugation and millipore filtration on the urinary protein content. In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG, eds. Urolithiasis. New York: Plenum Press, 1989: 593-4.
26. Grover PK, Ryall RL, Marshall VR. Does Tamm-Horsfall mucoprotein inhibit or promote calcium oxalate crystallization in human urine? Clin Chim Acta 1990; 190: 223-38.
27. Ryall RL, Harnett RM, Hibberd CM, Edyvane KA, Marshall VR. Effects of chondroitin sulphate, human serum albumin and Tamm-Horsfall mucoprotein on calcium oxalate crystallization in undiluted human urine. Urol Res 1991; 19: 181-8.
28. Ryall RL, Hibberd CM, Marshall VR. A method for studying inhibitory activity in whole urine. Urol Res 1985; 13: 285-9.
29. Robertson WG, Knowles F, Peacock M. Urinary mucopolysaccharide inhibitors of calcium oxalate crystallizatioin. In: Fleisch H, Robertson WG, Smith LH, Vahlensieck W, eds. Urolithiasis research. Plenum Press: New York, 1976: 331-4.
30. Kallistratos G, Timmermann A, Fenner O. Zum Einfluss des Aussalzeffektes auf die Bildung von calciumoxalat-Kristallen im menschlichen Harn. Naturwissenschaften 1970; 57: 198.
31. Kallistratos G, Timmermann A. The 'salting-out' effect as a possible causative factor for the formation of calcium oxalate crystals in human urine. Paper presented at the 66th annual meeting of the American Urological Association in Chicago, Illinois, USA, May 17, 1971, Urological Research Forum.
32. Pak CYC, Hayashi Y, Arnold LH. Heterogenous nucleation with urate, calcium phosphate and calcium oxalate. Proc Soc Exp Biol Med 1976; 153: 83-7.
33. Pak CYC, Holt K, Britton F, Peterson R, Crowther C, Ward D. Assessment of pathogenetic role of uric acid, monopotassium urate, monoammonium urate and monosodium urate in hyperuricosuric calcium oxalate nephrolithiasis. Miner Electrolyte Metab 19890; 4: 130-6.
34. Finlayson B, Reid F. The expectation of free and fixed particles in urinary stone disease. Invest Urol 1978; 15: 442-8.
35. Finlayson B, Khan SR, Hackett RL. Mechanisms of stone formation - an overview. Scan Electron Microsc 1984; 3: 1419-25.
36. McCulloch RK, Bowyer RC, Brockis JW. Possible roles of urate in calcium urolithiasis. In: Brockis JG, Finlayson B, eds. Urinary calculus. Littleton, MA: PSG Publishing Company, 1981: 347-52.
37. Grover PK, Ryall RL, Marshall VR. Calcium oxalate crystallization in urine: role of urate and glycosaminoglycans. Kidney Int 1992; 41: 149-54.
38. Grover PK, Ryall RL, Marshall VR. Dissolved urate promotes calcium oxalate crystallization: epitaxy is not the cause. Clin Sci 1993; 85: 303-7.